🇺🇸 FDA
Pipeline program

Eltrekibart, 0.9% sodium chloride

I7P-MC-DSAF

Phase 2 small_molecule active

Quick answer

Eltrekibart, 0.9% sodium chloride for Moderate to Severe Hidradenitis Suppurativa is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Moderate to Severe Hidradenitis Suppurativa
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials